Selzentry
Links shared publicly online about this topic
Selzentry and joint pain - Forum on Choosing Your Meds
thebody.com — “Hello and thanks for your follow up. While joint pains are uncommonly reported in clinical trials of maraviroc (SELZENTRY), it does appear more commonly among persons who took maraviroc than...” View full resource at thebody.com
Most Recently Shared on July 14, 2011 at 12:01 pm By:
Ask the HIV/AIDS Experts: "What's the Link Between Joint Pain and Selzentry?" http://bit.ly/qoFZVl #maraviroc #sideeffects
ViiV Healthcare highlights S/GSK1349572, SELZENTRY and EPZICOM for HIV/AIDS at 17th CROI
news-medical.net — “At the 17th Conference on Retroviruses and Opportunistic Infections (CROI), ViiV Healthcare presented new data across its broad range of investigational and current medicines for the treatment of HIV/AIDS. Highlighted data at the conference included an oral presentation on the investigational integrase inhibitor, S/GSK1349572, as well as data presentations on SELZENTRY® (maraviroc) and EPZICOM® (abacavir/lamivudine).” View full resource at news-medical.net
Most Recently Shared on February 24, 2010 at 6:11 am By:
ViiV Healthcare highlights S/GSK1349572, SELZENTRY and EPZICOM for HIV/AIDS at 17th CROI: At the 17th Conference o... http://bit.ly/bLdq7u
FDA Offers Pfizer's HIV Drug Selzentry New Life -- For All the Good It Will Do | BNET Pharma Blog | BNET
industry.bnet.com — “The FDA approved Pfizer’s anti-HIV drug Selzentry for expanded use in combination with other antiretroviral agents for treatment-nave patients” View full resource at industry.bnet.com
Most Recently Shared on November 30, 2009 at 7:24 pm By:
Jim Edwards Health Communicator
FDA Offers Pfizer's HIV Drug Selzentry New Life -- For All the Good It Will Do: The FDA approved Pfizer's anti-HIV ... http://bit.ly/84UPV3
FDA panel OKs expanded use of HIV drug - AIDS- msnbc.com
msnbc.msn.com — “Federal health advisers said Thursday that Pfizer's HIV drug Selzentry should be approved for use by patients who have not already taken other drugs to combat the virus.” View full resource at msnbc.msn.com
Most Recently Shared on October 8, 2009 at 7:24 pm By:
msnbc.com - Health Health News
FDA panel OKs expanded use of HIV drug http://bit.ly/2X2Va0
Indian Drugmaker Seeks to Make, Sell Generic Version of Pfizer's HIV Drug - The Body
thebody.com — “The Indian drugmaker Natco Pharma 'said Wednesday it has informed Pfizer Inc. that it wants to make and sell a low-cost generic version of the U.S. ...” View full resource at thebody.com
Most Recently Shared on January 5, 2011 at 9:01 pm By:
Indian Drugmaker Seeks to Make, Sell Generic Version of Pfizer's HIV Drug http://bit.ly/grLkEH #aids #maraviroc #selzentry
Medical News: IAS: Simpler HIV Regimen Shows Promise - in Meeting Coverage, IAS from MedPage Today
medpagetoday.com — “ROME -- Combination therapy employing maraviroc (Selzentry) and ritonavir-boosted atazanavir (Reyataz) appears effective in controlling HIV among treatment-naive patients, researchers reported here.” View full resource at medpagetoday.com
Most Recently Shared on July 20, 2011 at 8:32 pm By:
IAS: Simpler HIV Regimen Shows Promise (CME/CE): ROME (MedPage Today) -- Combination therapy… http://goo.gl/fb/s4h7D
HIV drug seems safe for new use: FDA staff | Lifescript.com
lifescript.com — “WASHINGTON (Reuters) - Pfizer Inc's HIV drug Selzentry appears to be safe for wider use in certain...” View full resource at lifescript.com
Most Recently Shared on October 6, 2009 at 8:35 pm By:
HIV drug seems safe for new use: FDA staff http://twurl.nl/6201mb
IAS: Simpler HIV Regimen Shows Promise (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “ROME (MedPage Today) -- Combination therapy employing maraviroc (Selzentry) and ritonavir-boosted atazanavir (Reyataz) appears effective in controlling HIV among treatment-naive patients, researchers reported here.” View full resource at qualitypointtech.net
Most Recently Shared on July 20, 2011 at 7:45 pm By:
IAS: Simpler HIV Regimen Shows Promise (CME/CE): ROME (MedPage Today) -- Combination therapy employing maraviroc (... http://bit.ly/oxbd4f
FDA sees no safety issues with Pfizer HIV drug - AIDS- msnbc.com
msnbc.msn.com — “The Food and Drug Administration said Tuesday an HIV drug from Pfizer appears safe for expanded use in patients who have not already taken other drugs to combat the virus.” View full resource at msnbc.msn.com
Most Recently Shared on October 7, 2009 at 12:35 am By:
msnbc.com - Health Health News
FDA sees no safety issues with Pfizer HIV drug http://bit.ly/6L3V7
ViiV Healthcare Presents New Data From HIV/AIDS Portfolio Demonstrating Research Advances And Commitment To Patient Care At Conference On Retroviruses
medicalnewstoday.com — “At the 17th Conference on Retroviruses and Opportunistic Infections (CROI), ViiV Healthcare presented new data across its broad range of investigational and current medicines for the treatment of” View full resource at medicalnewstoday.com
Most Recently Shared on February 23, 2010 at 2:11 pm By:
ViiV Healthcare Presents New Data From HIV/AIDS Portfolio Demonstrating Research Advances And Commitment To Patient Ca... http://mnt.to/3xY2
Medical News: FDA Panel Supports HIV Drug for Treatment-Naive Patients - in HIV/AIDS, HIV/AIDS from MedPage Today
medpagetoday.com — “WASHINGTON -- An FDA advisory panel has recommended that the agency approve the antiretroviral HIV drug maraviroc (Selzentry) for treatment-naive patients.” View full resource at medpagetoday.com
Most Recently Shared on October 9, 2009 at 12:59 am By:
FDA Panel Supports HIV Drug for Treatment-Naive Patients http://ow.ly/15TLyL
Question about a comment you made... - Forum on Nutrition and Exercise
thebody.com — “The older drugs (Zerit, AZT, Crixivan, old formulation of Kaletra, old formulation of Saquinavir, etc) were a lot more problematic than the newer ones (Isentress, Atripla, Reyataz, Selzentry,...” View full resource at thebody.com
Most Recently Shared on July 14, 2011 at 1:01 pm By:
Ask the HIV/AIDS Experts: "Is It Really Better to Start HIV Meds ASAP?" http://bit.ly/n3jyXs #starting
Cytheris initiates ORVACS Phase II clinical trial to study HIV infection
news-medical.net — “Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of Phase II clinical trial of the company's investigative immunomodulatory agent, CYT107 (rhIL-7), in combination with two potent antiretroviral drugs represented by the integrase inhibitor raltegravir (ISENTRESS- Merck & Co.) and the CCR5 inhibitor, maraviroc (SELZENTRY- ViiV Healthcare).” View full resource at news-medical.net
Most Recently Shared on October 19, 2010 at 5:08 pm By:
News-Medical.Net Health News and Oncology
Oncology News: Cytheris initiates ORVACS Phase II clinical trial to study HIV infection: Cytheris SA, a clinical s... http://bit.ly/8ZzQJs
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
The Body
The Complete HIV/AIDS Resource.
-
News-Medical.Net
Medical News from Around the World
-
Jim Edwards
Writer for CBS Interactive's BNET, Adweek and Brandweek.
Advertisement
